Evaluación de la gravedad en la neumonía del adulto adquirida en la comunidad

Clinical evolution in patients affected by community acquired pneumonia varies from a mild and low risk infectious disease to an extremely severe, life threatening disease. Commonly, immunocompetent adults without co-morbidities or severe risk factors cared for at out patient clinic have low risk of...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Saldías P,Fernando, Pavié G,Juana
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Chilena de Infectología 2005
Materias:	neumonía pronóstico evaluación de gravedad del paciente
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-10182005000400006
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0716-10182005000400006
record_format	dspace
spelling	oai:scielo:S0716-101820050004000062005-12-06Evaluación de la gravedad en la neumonía del adulto adquirida en la comunidadSaldías P,FernandoPavié G,Juana neumonía pronóstico evaluación de gravedad del paciente Clinical evolution in patients affected by community acquired pneumonia varies from a mild and low risk infectious disease to an extremely severe, life threatening disease. Commonly, immunocompetent adults without co-morbidities or severe risk factors cared for at out patient clinic have low risk of complications and death (mortality below 1-2%); it increases to 5-15% in patients with co-morbidities and/or with specific risk factors that are admitted into the hospital and reaches 20-50% in those patients admitted into ICUs. Evaluation of severity in patients with pneumonia allows the prediction of disease evolution, establishing the proper setting of care, the type- of microbiological tests needed, and to choose the best empiric antibiotic treatment. It is suggested that patients be in three risk categories: low risk (mortality under 1-2%) susceptible to ambulatory treatment; high risk patients (mortality 20-30%) that need specialized wards; and intermediate risk patients, with co-morbidities and/or risk factors for complicated clinical evolution and death, but cannot be classified in a specific category. In the ambulatory setting, without availability of complete laboratory exams, it is recommended to evaluating the severity of pneumonia considering the following clinical variables: age over 65 years, presence of co-morbidities, sensorial compromise, vital signs alteration, degree of radiological involvement: multilobar, bilateral findings, cavitations), pleural effusion and arterial oximetry < 90%. However, clinical judgement and the physician's experience must predominate over predictive models, which are not infallibleinfo:eu-repo/semantics/openAccessSociedad Chilena de InfectologíaRevista chilena de infectología v.22 suppl.1 20052005-01-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-10182005000400006es10.4067/S0716-10182005000400006
institution	Scielo Chile
collection	Scielo Chile
language	Spanish / Castilian
topic	neumonía pronóstico evaluación de gravedad del paciente
spellingShingle	neumonía pronóstico evaluación de gravedad del paciente Saldías P,Fernando Pavié G,Juana Evaluación de la gravedad en la neumonía del adulto adquirida en la comunidad
description	Clinical evolution in patients affected by community acquired pneumonia varies from a mild and low risk infectious disease to an extremely severe, life threatening disease. Commonly, immunocompetent adults without co-morbidities or severe risk factors cared for at out patient clinic have low risk of complications and death (mortality below 1-2%); it increases to 5-15% in patients with co-morbidities and/or with specific risk factors that are admitted into the hospital and reaches 20-50% in those patients admitted into ICUs. Evaluation of severity in patients with pneumonia allows the prediction of disease evolution, establishing the proper setting of care, the type- of microbiological tests needed, and to choose the best empiric antibiotic treatment. It is suggested that patients be in three risk categories: low risk (mortality under 1-2%) susceptible to ambulatory treatment; high risk patients (mortality 20-30%) that need specialized wards; and intermediate risk patients, with co-morbidities and/or risk factors for complicated clinical evolution and death, but cannot be classified in a specific category. In the ambulatory setting, without availability of complete laboratory exams, it is recommended to evaluating the severity of pneumonia considering the following clinical variables: age over 65 years, presence of co-morbidities, sensorial compromise, vital signs alteration, degree of radiological involvement: multilobar, bilateral findings, cavitations), pleural effusion and arterial oximetry < 90%. However, clinical judgement and the physician's experience must predominate over predictive models, which are not infallible
author	Saldías P,Fernando Pavié G,Juana
author_facet	Saldías P,Fernando Pavié G,Juana
author_sort	Saldías P,Fernando
title	Evaluación de la gravedad en la neumonía del adulto adquirida en la comunidad
title_short	Evaluación de la gravedad en la neumonía del adulto adquirida en la comunidad
title_full	Evaluación de la gravedad en la neumonía del adulto adquirida en la comunidad
title_fullStr	Evaluación de la gravedad en la neumonía del adulto adquirida en la comunidad
title_full_unstemmed	Evaluación de la gravedad en la neumonía del adulto adquirida en la comunidad
title_sort	evaluación de la gravedad en la neumonía del adulto adquirida en la comunidad
publisher	Sociedad Chilena de Infectología
publishDate	2005
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-10182005000400006
work_keys_str_mv	AT saldiaspfernando evaluaciondelagravedadenlaneumoniadeladultoadquiridaenlacomunidad AT paviegjuana evaluaciondelagravedadenlaneumoniadeladultoadquiridaenlacomunidad
_version_	1718440087078830080

Evaluación de la gravedad en la neumonía del adulto adquirida en la comunidad

Ejemplares similares